No revenue reported as Terns remains a clinical-stage, pre-commercial biotech. A strong cash position of $315.4 million as of Q2 2025 is expected to fund operations into 2028.

The outgoing chief executive of Novo Nordisk has revealed plans to ramp-up cost cutting 'efficiencies' across the business, ...

BRANCHBURG – Eli Lilly, a multinational pharmaceutical company headquartered in Indianapolis with $45 billion in annual sales, has confirmed that it is selling its facility on Imclone Lane off Route ...

Novo Nordisk A/S’s sales showed the weakest growth in four years as the Danish drugmaker loses ground to Eli Lilly & Co. in ...

That’s where the mental health implications come in. It’s traumatic to lose weight and regain it. Traumatic physically and ...